Global Coalition on Ageing (GCOA) ー 日本医療政策機構 共催
グローバル専門家会合「超高齢社会におけるイノベーション～テクノロジー・健康・介護・都市計画へのインパクト～」2018 年11月2日（金）A Joint Global Expert Meeting convened by GCOA and HGPIThe Impact of Innovation Across Technology, Health, Careand Urban Design for Super Ageing Societies
Friday, November 2, 2018

超高齢社会におけるイノベーション～テクノロジー・健康・介護・都市計画へのインパクト～
■日時：
■会場：

2018年11月2日（金）13時30分～18時45分
国際文化会館 岩崎小彌太ホール

13:00-13:30

会場・ネットワーキング

13:30-13:35

開会の辞

13:35-13:50

ラウンドテーブル参加者による自己紹介

13:50-14:05

基調講演「日本における超高齢化社会～現在とこれからの課題～」

14:05-14:55

セッション 1 「高齢者に優しいコミュニティづくりのための医療イノベーション」

14:55-15:05

休憩

15:05-15:15

コメント「接続可能高齢化社会形成に向けて求められるリーダーシップ」

15:15-16:05

セッション２「超高齢社会における21世紀の医療政策」

16:05-16:55

セッション３「超高齢社会における財政」

16:55-17:15

セッション 4「高齢者に優しい世界における連携」

17:15-18:45

レセプション*同時通訳あり・敬称略

The Impact of Innovation Across Technology, Health, Careand Urban Design for Super Ageing Societies■ Date & Time:■ Venue:

13:30-18:45, Friday, 2 November, 2018
International House of Japan , 5-11-16 Roppongi, Minato-ku, Tokyo

13:00-13:30

Arrivals and Networking

13:30-13:35

Welcome Remarks

13:35-13:50

Introductions

13:50-14:05

Keynote Remarks: Japan’s Super Ageing Society Today and Tomorrow

14:05-14:55

Session 1: Health Innovation for Age Friendly Communities

14:55-15:05

Health Break

15:05-15:15

Ambassador’s Remarks: The Leadership Imperative to Achieve Sustainable Ageing Societies

15:15-16:05

Session 2: 21st Century Health Policy for Super Ageing Societies

16:05-16:55

Session 3: Financing Super Ageing Societies

16:55-17:15

Closing Session: Partnerships for an Age Friendly World

17:15-18:45

Cocktail Reception*Simultaneous translation will be available throughout the event**Honorifics omitted

開会の辞 / ラウンドテーブル参加者による自己紹介
Welcome remarks / Introductions

13:30-13:50

Kiyoshi Kurokawa
Chairman, Health and Global Policy InstituteKiyoshi Kurokawa, MD, MACP; Professor Emeritus, National Graduate Institute for Policy Studies and the
University of Tokyo; Chairman, Health and Global Policy Institute; Member of World Dementia Council andInternational Scientific Advisory Committee (ISAC) member, Harvard T.H. Chan School of Public Health, JBL
Center for Radiation Sciences. A graduate of the University of Tokyo, Faculty of Medicine; he was aprofessor of medicine at the School of Medicine of UCLA (1979-1984), at the University of Tokyo (19891996), the Dean of the School of Medicine at Tokai University (1996-2002), President of Science Council ofJapan (2003-2006), Science Advisor to the Prime Minister (2006-2008), Executive member of many national
and international professional societies, WHO Commissioner (2005-2009), Institute of Medicine of National
Academies of Sciences of USA; and Chairman of Fukushima Nuclear Accident Independent Investigation
Commission by the National Diet of Japan (December 2011 – July 2012).

ファシリテーター Facilitators

Michael W. Hodin
CEO, Global Coalition on Aging
Michael W. Hodin, PhD is CEO of the Global Coalition on Aging, Managing Partner at High Lantern Group,
and a Fellow at Oxford University’s Harris Manchester College.
From 1976-80, Mike was Legislative Assistant to Senator Daniel Patrick Moynihan. During this period he wasalso a Visiting Scholar at Brookings Institution, on U.S. Foreign Economic Policy. He was a senior executive at
Pfizer, Inc. for 30 years, where he created and then led its International Public Affairs and Public Policy
operations and served on Management Boards for a number of its businesses.
Mike is a Member of the Council on Foreign Relations, and from 2010-2013, was Adjunct Senior Fellow witha focus on population aging. Mike was the recipient of the 2012 Fred D. Thompson Award from theAmerican Federation for Aging Research. He sits on the Boards of the Foreign Policy Association, BusinessCouncil for International Understanding, American Skin Association, American Federation for Aging
Research and Emigrant Savings Bank, where he is Chairman of its compensation committee. Mike was amember of the World Economic Forum’s Global Agenda Council on Ageing. And he sits on the Advisory
Board for the Milken Institute Center for the Future of Aging.
Mike holds a BA, cum laude, Cornell University, M.Sc. in International Relations from The London School of
Economics and Political Science, and M.Phil and Ph.D. in Political Science from Columbia University.

Ryoji Noritake
CEO, Board Member, Health and Global Policy Institute
Mr. Ryoji Noritake is CEO and board member of Health and Global Policy Institute (HGPI). He also serves as
a pro-bono consultant for Project HOPE, a US-based medical humanitarian aid organization. Through HOPE
and HGPI, he has led health system strengthening projects in the Asia-Pacific region and engaged in US
Navy's medical humanitarian projects. His focus is a multi-sectoral approach for health issues such as
public-private partnerships and civil-military coordination. He was a Working Group Member for the World
Health Organization's "Expert Consultation on Impact Assessment as a tool for Multisectoral Action on
Health" in 2012. He is a graduate of Keio University's Faculty of Policy Management, and holds an MSc in
Medical Anthropology from the University of Amsterdam, the Netherlands. He is currently a Visiting
Scholar at the National Graduate Institute for Policy Studies, a member of Tokyo Metropolitan
Government’s Policy Discussion Roundtable for Super Ageing Society.

基調講演「日本における超高齢社会～現在とこれからの課題～」13:50-14:05
Keynote Remarks “Japan’s Super Ageing Society Today and Tomorrow”
Keisuke Suzuki
State Minister of Finance, Government of JapanOn 22nd of October 2017, SUZUKI Keisuke was re-elected to the Member of the House of Representatives
and he was appointed to the State Minister of Finance since October 2018.
During his second and third term, he served as the Parliamentary Vice-Minister of Land, Infrastructure,
Transport and Tourism, the Parliamentary Vice-Minister of Cabinet Office, the Ranking member of theCommittee on Foreign Affairs, and the Committee on Rules and Administration in the House ofRepresentatives. He also had been appointed to the Head of Youth Division, the Deputy Secretary-General,
the Acting Director of Finance Policy Division, Foreign Policy Division, Environment Policy Division and also
the Deputy Director-General of International Bureau in LDP.
Keisuke is known as a principal member of the Working Team on North Korean issues, Structural Reform of
Budget (Road Construction) and Corporate Tax Reform. He belongs to Former Prime Minister Aso's group.
Before he elected to the Member of the House of Representatives in September 2005, he had worked as agovernment official for the Ministry of Finance (MOF) since 1999. He mainly worked in the division ofinternational finance and development policy. He also had experience of working as Examiner of Fukuoka
Regional Taxation Bureau, Vice Council & Financial Attache at Consulate General of Japan in New York andPolicy Section Chief of the Employment Measures for the Elderly and Persons with Disabilities Department
for the Ministry of Health, Labour and Welfare.
He studied political science and international law in the Faculty of Law, University of Tokyo, where he got
his Bachelor degree. But mainly he spent his years as the crew of the Rowing team of University of Tokyo.
He also spent a year as a Fellow in Foreign Service at Georgetown University.
He lives in Yokohama and serves as the Member of the House of the Representatives for Kanagawa 7thDistrict. He is also the Intellectual Member of the Policy Council, The Japan Forum on International Relations,
Inc. and the Secretary-General of GLOBE Japan.

基調講演「日本における超高齢社会～現在とこれからの課題～」13:50-14:05
Keynote Remarks “Japan’s Super Ageing Society Today and Tomorrow”
Nicholas Hill
Minister Counselor for Economic Affairs, U.S. Embassy Tokyo
A member of the Senior Foreign Service, Nicholas M. Hill is Minister Counselor for Economic and Science
Affairs. Prior to his assignment in Tokyo, he served for 18 months as Deputy Chief of Mission and 18
months as Charge d’Affaires at the U.S. Embassy in Bosnia and Herzegovina between 2012-2015. Mr.
Hill served as the Deputy Chief of Mission at the U.S. Embassy in Ulaanbaatar, Mongolia between 20082011. Prior to that he served as the Chief of Trade Policy at the U.S. Embassy in Tokyo. During his 30 year
career as a Foreign Service Officer, Mr. Hill has worked overseas at U.S. missions in Belgrade, Budapest,
Montreal, Sapporo, and Zagreb, as well as at the United Nations in New York and at the State Department
in Washington, D.C.
Mr. Hill holds a B.A. in History and Economics from Bowdoin College, a Masters in International Relations
from George Washington University, and a Masters in Security Studies from the National War College inWashington, D.C.

コメント

「持続可能な高齢化社会形成に向けて求められるリーダーシップ 」 15:05-15:15
Ambassador’s Remarks “The Leadership Imperative to Achieve Sustainable Ageing Societies”
Pekka Orpana
Ambassador-designate of Finland to Japan
Ambassador Orpana graduated with a Master of Laws from the University of Helsinki in 1979. From 1979
to 1982, he worked as a lawyer in the District Courts of Helsinki and Janakkala, and in the Municipalities
of Helsinki, Lahti and Kolari. In 1982, he was integrated into the diplomatic service of the Ministry for
Foreign Affairs of Finland. From 1982 to 1983, he served as Attaché at the Legal Department of the
Ministry for Foreign Affairs, at the Consulate of Finland in Marseille from 1983 to 1984, and at the Officefor the Western European Integration of the Ministry for Foreign Affairs from 1984 to 1985. From 1985 to
1988, he was the Second Secretary of the Embassy of Finland in Algiers, and from 1988 to 1991, the First
Secretary at the Embassy of Finland in London. He served again as First Secretary at the Office of Russia
and the Commonwealth of Independent States at the Ministry for Foreign Affairs from 1991 to 1994. He
then was Counsellor at the Mission of Finland to the United Nations in New York from 1994 to 1997, andCounsellor and Deputy Chief of Mission at the Embassy of Finland in Pretoria from 1997 to 2001. From2002 to 2007, he was Director of the Office of Central and South-Eastern Europe at the Ministry for
Foreign Affairs. From 2007 to 2011, he served as Ambassador of Finland in Lima, which was accredited toPeru, Ecuador, and Bolivia. From 2011 to 2015, he was Ambassador in Belgrade, which was accredited toSerbia and Montenegro, and Ambassador and Senior Adviser on Energy External Relations and Climate
Change Policies at the Ministry for Foreign Affairs from 2015 to 2018. Since September 2018, he has been
serving as Ambassador in Tokyo.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Masatomi Akana
Corporate Officer and Vice President of Corporate Affairs, Eisai Co., Ltd.
Masatomi Akana is Corporate Officer and Vice President of Corporate Affairs, Global Value and Access of
Eisai Co., Ltd. He joined Eisai in 1990, and has served as Manager of the Medical Regulatory Affairs
Department (2001–06) and Senior Manager of Global Regulatory Affairs at Eisai Europe Ltd. in London(2006–10). Mr. Akana graduated from the Department of Mathematics, Science and Engineering of Chuo
University in Tokyo in 1990, and received his M.B.A. from the Fuqua School of Business at Duke University,
North Carolina, in 2000.

Sarah Louise Barber
Director, WHO Kobe Centre
Dr. Sarah Louise Barber is a health economist and policy specialist, and holds doctorate and post-doctorate
qualifications from the University of California, Berkeley, USA, focusing on economic evaluation. Before
becoming Director of the WHO Kobe Centre, she worked on strategic policy issues with the World HealthOrganization, including as Senior Health Policy Advisor in the Office of the Regional Director for Africa,
WHO Representative to South Africa, Team Leader for Health Systems Development in China, and Health
Policy Advisor in Indonesia and Cambodia. Prior to working with WHO in China, she was managing
evaluation research at the University of California Berkeley’s Institute of Business and Economic Research,and the National Institute of Public Health in Mexico.
In South Africa, China, Indonesia and Mexico, she developed programs of technical cooperation andresearch to advance reforms to achieve universal health coverage. Over the past 25 years, she has
published widely on diverse topics in health economics and policy analysis, including the role of the private
health care sector, conditional cash transfers, human resources, insurance and provider payment reforms,
quality of care assessments, policies for essential medicines, monitoring and evaluation, migration, andfiscal policies.
A native English speaker, she enjoys learning languages and has studied Spanish, Khmer, Thai, andIndonesian.

David Gossack
Vice President for Asia at the U.S. Chamber of Commerce.
David Gossack, vice president for Asia at the U.S. Chamber of Commerce, develops Chamber programs andpolicies across the region. He concurrently serves as president of the U.S.-Japan Business Council (USJBC)
and president of the U.S.-Korea Business Council (USKBC) where he helps lead U.S. business engagementwith two of America’s most important trading partners.
Prior to joining the Chamber, Gossack spent more than 24 years in Asia as one of America’s most seniorcommercial diplomats and an advocate for American business interests. He served in East Asia’s largest
economies before retiring in July 2018 as a career member of the Senior Foreign Service, MinisterCounselor rank. He served in Tokyo, Bangkok, Beijing, Seoul, Jakarta and Shanghai and received many
awards for distinguished performance including the Commerce Department’s Gold Medal.
Earlier, Gossack was legislative counsel to Sen. Spark Matsunaga (D-HI) during his chairmanship of the
Senate Finance Committee’s International Trade Subcommittee, and he was a participant in drafting major
trade legislation in the 100th and 101st Congresses. Also, he served as a foreign service officer for theState Department holding positions in Washington, Tokyo, and at the USTR’s Office of Japan Affairs.
Gossack is a native of San Jose, California, and a graduate of Stanford University and the University ofWashington School of Law. He resides in Potomac, Maryland.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Akihisa Harada
President & Representative Director, Pfizer Japan Inc.
Dr. Akihisa Harada is the President & Representative Director of Pfizer Japan Inc. (December, 2017~)
He joined Pfizer as Director for Clinical Research in 1999. He became the acting Head of Regulatory from2004 and the Head of Clinical Research from 2005. In 2008 he was appointed to the Vice President ofDevelopment Japan. In addition to his role as the head of Development Japan, he was also a Chief Scientist
in Pfizer Japan, responsible for leading Pfizer’s interactions within Japan’s scientific community andassociated stakeholders. As the Chief Scientist, he served as a point of contact within Pfizer for membersof Japan’s scientific community and provided guidance to Pfizer’s R&D leaders on appropriate strategies
for engaging with Japan’s scientific communities and leveraging Japan’s biomedical innovation potential.
And then appointed Inflammation & Immunology Japan Lead from 2016-2017.
Dr. Harada graduated from School of Medicine, Kanazawa University and obtained M.D. in 1986. He wastrained in Internal Medicine and obtained Doctor of Medical Science from graduate school in Kanazawa
University in 1990. He had pursued his career in research field in Immunology and appointed as Visiting
Scientist as Windeyer Institute, University College London, UK in 1997 before joining Pfizer.

Yuko Harayama
Former Executive Member of the Council for Science and Technology Policy at the
Cabinet Office of Japan
Dr. Yuko Harayama is the former Executive Member of the Council for Science and Technology Policy,
Cabinet Office of Japan. She is the former Deputy Director of the Directorate for Science, Technology andInnovation, OECD. She is a Legion D’Honneur recipient (Chevalier), and was awarded honorary doctorate
from the University of Neuchâtel. Previously, she was Professor in the Department of Management
Science and Technology at the Graduate School of Engineering of Tohoku University. She holds a Ph.D. ineducation sciences and a Ph.D. in economics, both from the University of Geneva.

Lyo Inuyama
Operating officer and Head of Medical Affairs, Bayer Yakuhin, Ltd.

Dr. Lyo Inuyama is currently serving as Operating officer, and Head of Medical Affairs at Bayer Yakuhin, Ltd.
After graduating from Tokyo Women’s Medical University, she worked as clinician in Ear, Nose and Throat.
(Otolaryngologist). She started a career in pharmaceutical industry in 1997. After working in a few Japan
based global pharma companies, she has been working in Bayer Yakuhin, Ltd. since 2008.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Marco Ivancic
Operations Lead, Home Instead Senior Care.
Marco Ivancic is an international professional in business operations and efficiencies. Marco has morethan 30-years of global experience in various industries including franchising, retail and wholesale
distribution as well as the commodities and financial derivatives trading industry.
Currently, Marco oversees relationships with Home Instead Senior Care’s global partners with a specificfocus on operational efficiencies and collaboration. His responsibilities involve obtaining and leveraging
key business insights; gathering global Key Performance Indicators and corresponding analysis, as well as
developing new multi-national business strategies and initiatives.
Marco leads international business roundtables as well as organizing and facilitating multi-day workshops
for global subject matter experts within the Home Instead network.

Patrik Jonsson
Representative Director and President, Eli Lilly Japan K.K.
Patrik Jonsson joined Eli Lilly & Company in 1990 and was appointed President and General Manager for Eli
Lilly Japan effective January, 2014.
Prior to 2014, Patrik held several positions within Eli Lilly & Co. He began his career with Lilly in Sweden asa sales representative followed by several sales and marketing roles both in Sweden and the UK before
being appointed European Marketing Director for Zyprexa and the Neuroscience Customer Group. In
2001, he was promoted toManaging Director Sweden and then to Managing Director Scandinavia (Sweden,
Norway and Denmark). In 2008, he was appointed President and General Manager for Eli Lilly Italia, and in2012 when Lilly in Europe announced a new structure of its
European business, Patrik assumed additional responsibilities for the countries in the South East andCentral Europe.
Patrik was born in Sweden and received bachelor’s and master’s degrees inbusiness administration from Lund University in Sweden.
Patrik is Chairman of the Japan Based Executive Committee of PhRMA and also serves on the boards ofAmerican Chamber of Commerce in Japan.
Patrik is one of the male business leaders in Japan who affirmed a “Declaration on
Action” to create “A Society in which Women Shine” supported by the Japanese
Government and various business sectors.

Mitsunobu R Kano
Professor and a Vice Executive Director, Okayama University.
Dr. Kano has experienced clinical medicine including gerontology, research in medical engineering andpharmaceutical sciences, and public services including academy activities and governmental commitments.
The public services led him to efforts in developing education for general sciences, including
implementation of achieving the United Nation’s Sustainable Development Goals (SDGs) into university
administration in Okayama University. Dr. Kano graduated from and started research activity in Universityof Tokyo, did his clinical residency in St. Luke's International Hospital, and is now Professor and a Vice
Executive Director in Okayama University. As the latter role he led the university to be awarded by theJapanese government for achieving the SDGs in 2017, and now serves as Chair of SDGs Initiatives Planning
Committee. Meanwhile he led to establish a new interdisciplinary graduate school focusing on the healthcare systems in the university including faculties from medical sciences, engineering, social sciences, andhumanities, started in April 2018. Dr. Kano was the former Deputy Chair of the Young Academy Japan, anda former Executive Committee member of the Global Young Academy (GYA).

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Gail Kohn
Coordinator, Age-Friendly DC
Currently Mrs. Kohn is the World Health Organization Age-Friendly DC Coordinator. She is responsible to
the Mayor for implementing with WHO guidance, the District’s transformation to an easier jurisdiction inwhich to grow up and grow older. In November 2017, after five years of listening, planning, implementing
government and community-wide strategies, the World Health Organization and its United States agent,
AARP joined the Mayor at a press conference to recognize the outstanding work completed by AgeFriendly DC.
Over the last year Mrs. Kohn facilitated the establishment of the city’s second five-year strategic plan.
Age-Friendly DC 2023 is built around three pillars: Improving the Built Environment, Changing Attitudes
about Growing Older, and Lifelong Health and Security. The plan was recently presented to DC residents
and WHO by the Mayor. Implementation has already begun.
Throughout her career, Kohn has planned and administered innovative residences and programs forpeople who have reached 60 and beyond. She is known for striving for excellence herself and for urging
colleagues to meaningfully engage older adults in governance and staffing the national, state and localorganizations, she has led.

Yukihiro Matsuyama
Research Director, Canon Institute for Global Studies
Yukihiro Matsuyama, PhD, is Research Director, the Canon Institute for Global Studies, Affiliate Professor,
Chiba University of Commerce and Honorary Professor, the Australian Institute of Health Innovation, theFaculty of Medicine and Health Sciences at Macquarie University. His research examines the sustainabilityof safety-net systems in Japan including healthcare, pension, pandemic crisis and employment throughinternational comparative analyses. He has served as government committee members including amember of the Welfare Committee. He has published many books on the subject.

Matt McEnany
Manager, HGPI
Matt McEnany joined HGPI in 2018. He is responsible for the Institute’s work on antimicrobial resistanceand emerging healthcare innovations. Mr. McEnany holds a Master of Public Health in Epidemiology with a
Certificate in Global Health from Columbia University. While attending Columbia, he was posted for half ayear at a World Health Organization (WHO) Collaborating Center, the Shanghai Mental Health Center,
where he researched drug abuse in the People's Republic of China and worked to support the localizationand validation of the 11th Revision of the International Classification of Diseases (ICD-11). Following that, Mr.
McEnany worked for New Jersey-based Genesis Research LLC, where he served as Senior Epidemiologist
primarily in charge of post-market pharmacoepidemiologic studies dealing with mental health disorders andprescription opioids. Mr. McEnany is an expert in Big Data healthcare research, with experience planningand executing studies including as many as 100+ million patients across dozens of US and international
databases. He also has over ten years of experience working in communications in the public sector,
creating mainly press materials for Japanese central government ministries, United Nations agencies, andmultinational pharmaceutical companies.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Paul McGarry
Head, Greater Manchester Ageing Hub and Age friendly Manchester, Manchester City
CouncilPaul McGarry is the Head of the Greater Manchester Ageing Hub, part of the Greater Manchester
Combined Authority tasked with making Greater Manchester the UK’s first Age-Friendly city region. Since
2003 he has led the Age Friendly Manchester Programme at Manchester City Council, formerly called
Valuing Older People. Under Paul’s leadership, Manchester became the first UK city to achieve WHO Age
Friendly status and was a founding member of both the WHO’s Global Network of Age-Friendly Cities andCommunities and the UK Network of Age-Friendly Cities.

Takaoh Miyagawa
Senior Leader, Corporate Management, AEGON Sony Life Insurance Co., Ltd.
Born in Yokohama, Kanagawa, Japan. MBA from Yale School of Management with emphasis on finance andinvestment.
Joined Aegon Sony Life in December 2011 and has been engaged in the annual global retirement research,
the AEGON Retirement Readiness Survey, in collaboration with AEGON and Aegon Center for Longevity
and Retirement for seven years since 2012. This survey examines retirement insecurities around the world,and found that while due to aging population the governmental pensions and traditional corporate DB
pension plans are under financial strain and individuals are expected to take on increasing risk andresponsibility for self-funding a greater portion of their retirement, many people, however, areinadequately equipped to successfully to do so and are therefore at risk of not achieving a financiallysecure retirement.
He has been in the retirement industry for more than 20 years, from the DB corporate pension fundmanagement, the DC pension plan management, and the variable annuity life insurance business. As aformer researcher in finance, he was specialized in the asset-liability management of the pension fund andthe asset allocation of investment fund with strong knowledge of investment theories, financial
engineering and financial modeling.
Spends his free time riding bicycles, watching baseball games in his hometown of Yokohama, and also
supporting his favorite Yokohama football club on weekends.

Hiroaki Miyata
Professor of Health Policy and Management, School of Medicine, Keio University
Dr. Hiroaki Miyata is Professor of Health Policy and Management at the School of Medicine at Keio
University, and is Director of Global Health Systems and Innovation at National Center of Global Healthand Medicine. After receiving his doctoral degree in Epidemiology, he has worked as a faculty in the
Department of Healthcare Quality Assessment at the Graduate School of Medicine, the University of Tokyo
which he currently remains affiliated to as an Adjunct Professor. He has been involved in numerous studies
related to the assessment and improvement of healthcare quality in Japan using the national clinicaldatabase which is a nationwide clinical registry database that he had actively participated as one of themain leaders in its development.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Toshihiko Morita
Director for Planning, Planning Division, Office of the Governor for Policy Planning, Tokyo
Metropolitan Government
Director for Planning, Planning Division in the Office of the Governor for Policy Planning of the Tokyo
Metropolitan Government. Entered the Tokyo Metropolitan Government in April 2004. Mr. Morita was
appointed to his current position in April 2018 following appointments in the Bureau of Waterworks andBureau of Olympic and Paralympic Games Tokyo 2020 Preparation. Mr. Morita leads the Secretariat of the
Policy Discussion Roundtable for Super Ageing Society within the Office of the Governor for Policy Planning,which is responsible for formulating the basic plans implemented by the Tokyo Metropolitan Government.
Mr. Morita is a graduate of the University of Tokyo Faculty of Law.

Shinsuke Muto
President, Tetsuyu Institute Medical Corporation
With two decades of experience in the field of medicine, Dr. Shinsuke Muto is a certified internal medicine
specialist and cardiologist who passed the US medical licensing examination (California) and holds both US
CPA (Delaware) , EMBA (INSEAD), MPH (Johns Hopkins).
After graduating from the Faculty of Medicine at the University of Tokyo in 1996, he received his doctorate
later in 2002. With experience in cardiovascular internal medicine and emergency medicine, he also
served as a court physician to the Imperial Household Agency before joining McKinsey & Company. In
2010, he launched Tetsuyu Institute Medical Corporation in Japan.
In 2015, he established Tetsuyu Healthcare Holdings with his INSEAD colleague in Singapore, and becamea chairman of Integrity Healthcare in 2016.

Kazumi Nishikawa
Director of Healthcare Industries Division, Commerce and Service Industry Policy Group,
METI
Kazumi Nishikawa is director of the Healthcare Industries Division at the Commerce and Service Industry
Policy Group at the Ministry of Economy, Trade and Industry (METI). His former responsibilities include
those of Deputy Director of the Defense Policy Division at the Japan Defense Agency (Ministry of Defense)from 2004 to 2006, and of the Multilateral Trade System Department of METI from 2006 to 2008. From2008 to 2009, he served as Principal Deputy Director of the Small and Medium Size Enterprises Finance
Division of METI, and of the Policy Planning and Coordination Division at the Minister’s Secretariat also at
METI from 2009 to 2012. From 2012 to 2013, he was Director for Policy Planning (Growth Strategy) at the
Economic and Industrial Policy Bureau of METI, and from 2013 to 2016, the Executive Director of Japan
External Trade Organization (JETRO) Singapore as well as Special Advisor to the Minister of METI. From2016 to 2017, he was Director of Trade Strategy at the Trade Policy Bureau, and of the Global Economic
Policy Unit at the Minister’s Secretariat at METI.
Mr. Nishikawa graduated with a BA from the faculty of Law of the University of Tokyo in 1996, an LLM
from Northwestern University’s School of Law in 2003, and obtained another LLM in International Study
from Georgetown University Law Center in 2004. He was also Attorney at Law in New York State, USA.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Kazumasa Oguro
Professor, Faculty of Economics, Hosei University
Kazumasa Oguro graduated from the Faculty of Science of Kyoto University and holds a PhD in economics
from Hitotsubashi University. In 1997, he joined the Ministry of Finance and worked as Assistant to theLegal Examination Officer at the Administration and Legal Division of the Minister’s Secretariat, Assistantat the Enforcement Division of the Customs and Tariff Bureau, and Research Fellow at the Policy ResearchInstitute of the same ministry. This was followed by a position as associate professor at the Institute of
Economic Research at Hitotsubashi University, after which, he joined Hosei University in April 2015, and hehas been there ever since. He is also active as a Senior Visiting Researcher at the Ministry of Finance’s
Policy Research Institute, a Consulting Fellow at the Research Institute of Economy, Trade and Industry,
and involved in the promotion of the Ministry of Health, Labour and Welfare’s “Japan Vision: Healthcare
2035.” He also serves on the Ministry of Health, Labour and Welfare’s Expert Committee on the Economic
Premises of the Social Security Council’s Pension Bureau and Pension Financing. Professor Oguro is amember of the Japanese Cabinet Office’s Committee for Regulatory Sandbox in Japan. Furthermore, he is
Director at the Kajima Institute of International Peace and the Institute for New Era Strategy, and a SeniorResearch Fellow at the Canon Institute for Global Studies. His expertise is in Public Economics.

Kanoko Oishi
CEO, Mediva Inc.
Kanoko Oishi is a graduate of Osaka University School of Law (valedictorian) and a holder of an MBA from
Harvard Business School.
Kanoko founded Mediva Inc., a consulting company specializing in healthcare, in 2000 after working as apartner at McKinsey & Company in both Japan and the US. Kanoko is the founder and CEO of Mediva Inc.
as well as the founder and COO of Medical Corporation Platanus, a healthcare provider arm of Mediva.
Mediva not only provides consulting services but also develops and operates unique healthcare andnursing care services, including elderly day care services focusing on functional training, in-home medicalcare, and community nursing.
Kanoko has served on numerous governmental committees, including at the Ministry of Health, Labor andWelfare, the Ministry of Economy, Trade and Industry and the Cabinet Secretariat. She is currently amember of the Economy and Social Structure Committee in the Industrial Structure Council at the
Ministry of Economy, Trade and Industry.
She is on the board of directors of Shiseido Japan Co., Santen Pharmaceutical Co., Ezaki Glico Co., Kameda
Service Kameda Inc., etc. She is also a member of the Japan Advisory Board at Harvard Business School,
and a member of the Management Council at Osaka University.
Kanoko is the co-author of various health care management books including “The Text Book of Clinic
Management” and “The Text Book of Hospital Management”, which are both top sellers of the category.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Melinda M. Pavek
Science, Innovation and Development Unit Chief, Economic and Scientific Affairs, U.S.
Embassy Tokyo
Melinda Pavek joined the Economic Section as Unit Chief for Science, Innovation and Development in July,
2018.
Melinda joined the Department of State in 2004. Her recent assignments include Supervisory General
Service Officer (U.S. Embassy Islamabad, Pakistan), and Deputy Chief of Mission (U.S. Embassy Bandar Seri
Begawan, Brunei). She served overseas in Nepal (Kathmandu), Jamaica (Kingston), Iraq (Baghdad), andPakistan (Lahore) and domestically in Washington, DC in the Bureau of Administration.
Before joining the Foreign Service, Melinda worked for Johnson & Johnson (J&J) as a supply chain senior
analyst, was a consultant and project manager who implemented quality management systems using Six
Sigma and ISO 9000 standards and taught English as a Second Language in Miyagi, Japan.
Raised in Minnesota but now a resident of Wyoming, Melinda earned a Master’s degree in Business
Administration (MBA) in Operations, Supply Chain and Strategy from the Carlson School of Management at
the University of Minnesota. Melinda earned her Bachelor of Arts degree from Augustana College (RockIsland, Illinois) in Political Science, Economics and Asian Studies.
Melinda is partnered with Brandon, a finance, consulting, and trading professional based in Chicago.

David P. Ryan
General Manager, Health & Life Sciences Sector, Internet of Things Group, Intel
Corporation
Dave leads the Health and Life Sciences business at Intel’s IoT Group to help the global health & life
sciences device industry transform care at the edge. His customers are the manufacturers who build life
sciences research instruments as well as medical equipment, appliances and devices used in hospitals,
clinics, residential care settings and the home. Dave is on the HIMSS’ Personal Connected Health Allianceboard of managers and the Governing Board of the Global Coalition on Aging.
Dave has spoken worldwide on the challenges and opportunities in an aging world – including United
Nations, OECD, national ministerial events and Asia HIMSS. His call for a new social contract across ages
was published in the AARP International Journal. He founded Intel’s China HLS unit, was on the American
Chamber of Commerce’s China Health Cooperation Program Steering Committee. He also led the buildout of Intel’s worldwide Age Friendly Initiative engagements on aging across APEC to OECD, WHO and G20.
Dave holds a B.S. Electrical Engineering from Arizona State University, an M.B.A. from Pennsylvania State
University and is a Wharton Fellow. He is Chairman of the Board for a worldwide non-profit dedicated to
improving infant care (www.RIE.org).

Masami Sakoi
Assistant Minister, Health Policy Bureau, Ministry of Health, Labour and Welfare (MHLW)
Masami Sakoi graduated from the Department of Medicine at the University of Tokyo in 1989. After three
years of practice as a gastroenterological surgeon, he joined the MHLW in 1992. Since then, he has servedin several posts within the MHLW and the other public sectors including Director of Medical Economics
Division, Director of Medical Care Planning Division, Director of Aging and Health Division and Director of
Health Security and Crisis Management. He also served as Director General of Health and Welfare
Department in Hiroshima Prefectural Government. He received Master’s degree in Public Health from
Harvard University School of Public Health in 1997.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Jiro Seguchi
Head of Asia Pacific Global Corporate & Investment Banking Country Executive for Japan
Bank of America GroupJiro Seguchi is the head of Asia Pacific Global Corporate & Investment Banking (GCIB) and country
executive for Japan. He is a member of the firm’s Asia Pacific Executive Committee.
Jiro has been leading Asia Pacific GCIB either as co-head or sole head, based in Hong Kong and Tokyo
since 2009. Jiro also has been country executive for Japan and President of Merrill Lynch Japan
Securities Co., Ltd. since July 2016 and between July 2010 and January 2014. Prior to that, he also
served as head of Japan Origination, running both Investment Banking and Capital Markets. Before
that, he was head of Japan Capital Markets & Financing, responsible for all debt and equity origination
activities in Japan. He originally joined Merrill Lynch as a director of Debt Capital Markets in 1999 andwas appointed managing director in 2002. He became a member of the Board of Directors of Merrill
Lynch Japan Securities in 2006.
Jiro started his career with Bank of Tokyo (currently MUFG Bank) in 1986 where he engaged in various
capital markets businesses including debt origination for corporations, sovereigns, supranational andinternational financial institutions as well as in the private placement business in New York.

Jiro holds a bachelor’s degree in Economics from The University of Tokyo and an MBA from Harvard
Business School.

Kenji Shibuya
Professor and Chair, Department of Global Health Policy,
Graduate School of Medicine, University of Tokyo
Dr. Shibuya is Professor and Chair of Global Health Policy at the University of Tokyo’s Graduate School of
Medicine, President of the Japan Institute for Global Health, and Director of Institute for Global Health
Policy Research, National Center for Global Health and Medicine. He obtained his MD at the University ofTokyo and his doctorate in international health economics at Harvard University. After teaching at Teikyo
University in Tokyo, he joined the WHO’s Global Programme on Evidence for Health Policy in 2001 and waschief of the Health Statistics and Evidence Unit from 2005 until 2008. He has published widely on mortality,
causes of death, burden of disease, risk factors, cost-effectiveness, priority setting, health system
performance assessment and health diplomacy. He spearheaded the future strategic directions of theJapanese global health policy agenda after the Hokkaido Toyako G8 Summit in 2008. He led the Lancet
Series on Japan, published in 2011 in an effort to jump-start debates on Japanese domestic and global
health policy reform. He is currently an advisor to both central and local governments. This year he chaired
the landmark Advisory Panel on Health Care 2035 for the Minister of Health, Labour and Welfare. He iscurrently the Executive Advisor on Global Health for the Ministry of Health, Labour and Welfare.

パネルディスカッション
Panel Discussion

14:05-17:15

パネリスト（アルファベット順） Panelists (listed in alphabetical order)

Kenji Shuto
Vice Governor, Kanagawa Prefectural Government
Dr. Kenji Shuto is Vice Governor, Kanagawa Prefectural Government.
Dr. Shuto received his MD degree from the School of Medicine, Kyoto University in 1991, and the Master of
Public Health degree from Harvard University in 1997.
He joined Ministry of Health and Welfare in 1993. Since then, He was in charge of various health care policy
reforms.
In 2011, he moved to the Medical Innovation Office, Cabinet Secretariat, Government of Japan, which is
the headquarters of the country to accelerate “Medical Innovation in Japan.”In 2012, He joined Kanagawa Prefectural Government and in 2013 he was appointed as Special Assistant to
the Governor, before he was assigned to the current position of Vice Governor in 2017.

Brian C. Toohey
Senior Vice President for International Advocacy, PhRMA
Brian C. Toohey is the Senior Vice President for International at the Pharmaceutical Research &Manufacturers of America (PhRMA), where he is responsible for international intellectual property, pricing& reimbursement, and science and regulatory activities. Previously, he was the President & CEO of the
Semiconductor Industry Association (SIA) and Executive Vice President of DEKA Research & Development
Corporation. Earlier in his career, he was Vice President of wireless network operator and service provider
AirCell, Inc. and Director of International Government Affairs and Managing Director of the European
business unit at the global satellite company, Iridium LLC. Prior to joining the private sector, Mr. Toohey
worked for several years at the U.S. Department of Commerce, primarily on European trade andintellectual property issues.
Mr. Toohey received his undergraduate and graduate degrees from the Georgetown University School of
Foreign Service. He is a member of the U.S. Department of Homeland Security Science and Technology
Advisory Committee and was a members of the U.S. Department of Commerce’s and United States Trade
Representative’s International Trade Advisory Committee. He is Senior Advisor to F.I.R.S.T., a leading
nonprofit organization that brings science and technology to America’s schools. Mr. Toohey was Chairmanof the Beijing-based U.S. Information Technology Organization (USITO) and a board member of the
Semiconductor Research Corporation and the Semiconductor Industry Association. A Boston native, Mr.
Toohey and his wife reside in Washington, DC.